Prognostic significance of serum B-lymphocyte stimulator in Hodgkin's lymphoma.

@article{Oki2007PrognosticSO,
  title={Prognostic significance of serum B-lymphocyte stimulator in Hodgkin's lymphoma.},
  author={Yasuhiro Oki and Georgios V. Georgakis and T Migone and Larry W. Kwak and Anas Younes},
  journal={Haematologica},
  year={2007},
  volume={92 2},
  pages={269-70}
}
B-lymphocyte stimulator (BLyS) plays a critical role in the survival of B-lymphocytes. In 50 patients with Hodgkin's lymphoma BLyS levels were higher in newly diagnosed patients (median 2.0 ng/mL, range <0.3-56.0) and relapsed patients (8.7 ng/mL, range 1.5-71.5) than in 93 healthy donors (<0.3 ng/mL, range <0.3-0.5). High serum BLyS levels (> or =2.0 ng/mL… CONTINUE READING